Asthma and other lung diseases

Occupational lung disease

Much of IOMs research has been concerned with understanding the relationships between workplace exposures and lung diseases. Our original programme of research was in the British coal industry, investigating how much dust could be inhaled without harming the miner’s lungs, particularly causing coal workers pneumoconiosis or ‘black lung’. The research has been used to set the standards in coal mines around the world.

Since then we have also investigated cancers caused by exposure to asbestos, asthma from inhaling opiates and most recently the potential of nanoparticles to cause lung disease. We continue to investigate a wide range of dust and chemical exposures in relation to the risk of lung disease.

What our scientists do:

We have particular skills in measuring or modelling occupational exposures and linking these to the risk of lung disease in epidemiological studies. In a collaboration with scientists from the USA and Europe, we studied the risks for workers manufacturing ‘hard metal’, which is composed of tungsten carbide along with cobalt or nickel. This study, which involved over 30,000 workers from 17 manufacturing sites and found no evidence these exposures increased the risk of death from lung cancer or any other disease.

Our studies have included investigation of exposure to isocyanates, the main cause of occupational asthma in the UK. Our research showed that in some industry sectors the respirators being used to protect workers were ineffective in controlling exposure or that absorption of the isocyanate was entering the body through the skin rather than by inhalation. This work suggested better controls were needed to reduce the risk for workers.

The main sponsors for our research on lung disease have included large industries, the European Commission, UK and other national government agencies.

  • IOMworld Posted: 3 days ago
    New research gives clear advice for employers on managing musculoskeletal disorders (MSDs) in the workplace.… https://t.co/VAjBtjom6w
  • IOMworld Posted: 3 days ago
    We have published over 2,500 articles and major pieces of project work. Today we are one of Europe’s principal work… https://t.co/t5Gc07YYP5
  • IOMworld Posted: 4 days ago
    One in four of the population suffer from chronic musculoskeletal disorders (MSDs). Discover good practice advice o… https://t.co/ENeRWMBlHA
  • IOMworld Posted: 4 days ago
    Restrict the transmission of the #COVID19 virus in the workplace with a #COVID19 workplace risk assessment. Find ou… https://t.co/15jhgFZpkd
  • IOMworld Posted: 17 days ago
    Last chance to get involved the future of healthy working by taking part in the EPHOR survey and be part of ground… https://t.co/T8Y5M84RuC
  • IOMworld Posted: 20 days ago
    Use your expert knowledge and be a part of ground-breaking research on developing innovative methods for working-li… https://t.co/FGcuKD0qHF
  • IOMworld Posted: 22 days ago
    Find out how you can help to advance occupational health science in a unique way to reduce the burden of disease. C… https://t.co/70Vl3Qv1EL
  • IOMworld Posted: 24 days ago
    We have published over 2,500 articles and major pieces of project work. Today we are one of Europe’s principal work… https://t.co/C2daujZVK7
  • IOMworld Posted: 25 days ago
    #NanoTox2021 is taking place online from 20th – 22nd April 2021 ➡️Nanotechnology ➡️ Hazard and risk assessment of n… https://t.co/JC30t6iKhf
  • IOMworld Posted: 26 days ago
    Talking about the physical and emotional aspects of working from home & how it impacts both organisations & humans… https://t.co/OYw7dsIvHF